Sayfa yüklenirken bir hata oluştu.
Teknik ekibimiz bilgilendirildi, ancak sorunun devam etmesi durumunda lütfen e-posta destek widget ile bize ulaşın.
| Trend | Peers | Company |
|---|---|---|
| Is return on equity increasing? | Yes | Yes |
| Is net profit margin increasing? | Yes | Yes |
| Is asset turnover increasing? | Yes | No |
| Is equity multiplier increasing? | No | No |
| Competitors Used |
|---|
| Bio-Techne Corporation |
| Revvity, Inc. |
| Thermo Fisher Scientific Inc. |
| Mesa Laboratories, Inc. |
| Azenta, Inc. |
| Return on Equity Benchmarks | ||||||||
| Comparable Companies | ||||||||
| TECH | RVTY | TMO | MLAB | AZTA | DAP | |||
| Return On Equity | ||||||||
| Latest Twelve Months | 7% | 4% | 14% | -1% | -9% | 7% | ||
| Fiscal Year - 1 | 16% | 2% | 13% | -94% | 0% | 8% | ||
| Fiscal Year - 2 | 17% | 7% | 16% | 0% | 0% | 14% | ||
| Fiscal Year - 3 | 10% | 16% | 21% | 0% | -2% | 13% | ||
| Fiscal Year - 4 | 18% | 19% | 20% | 1% | -2% | 11% | ||
| Fiscal Year - 5 | 9% | 8% | 13% | 1% | -7% | 8% | ||
| Average | 12% | 10% | 16% | -15% | -3% | 10% | ||
| Median | 13% | 8% | 15% | 0% | -2% | 10% | ||
| Benchmarks | Ticker | |||||||
| Bio-Techne Corporation | NasdaqGS:TECH | |||||||
| Revvity, Inc. | NYSE:RVTY | |||||||
| Thermo Fisher Scientific Inc. | NYSE:TMO | |||||||
| Mesa Laboratories, Inc. | NasdaqGS:MLAB | |||||||
| Azenta, Inc. | NasdaqGS:AZTA | |||||||
| Financial Performance | ||||||||
| Comparable Companies | ||||||||
| (in millions) | TECH | RVTY | TMO | MLAB | AZTA | DAP | ||
| Latest Fiscal Year | Jun-24 | Dec-24 | Dec-24 | Mar-25 | Sep-24 | Dec-24 | ||
| LTM Period | Mar-25 | Mar-25 | Mar-25 | Mar-25 | Mar-25 | Jun-25 | ||
| Revenues | ||||||||
| Latest Twelve Months | 1,209 | 2,770 | 42,898 | 241 | 669 | 24,013 | ||
| Fiscal Year | 1,159 | 2,755 | 42,879 | 241 | 656 | 23,875 | ||
| Fiscal Year - 1 | 1,137 | 2,751 | 42,857 | 216 | 665 | 23,890 | ||
| Fiscal Year - 2 | 1,106 | 3,312 | 44,915 | 219 | 555 | 26,643 | ||
| Fiscal Year - 3 | 931 | 3,828 | 39,211 | 184 | 514 | 24,802 | ||
| Fiscal Year - 4 | 739 | 2,663 | 32,218 | 134 | 389 | 22,284 | ||
| Fiscal Year - 5 | 714 | 2,884 | 25,542 | 118 | 334 | 17,911 | ||
| Net Income | ||||||||
| Latest Twelve Months | 132 | 296 | 6,514 | (2) | (168) | 3,413 | ||
| Fiscal Year | 168 | 283 | 6,335 | (2) | (164) | 3,899 | ||
| Fiscal Year - 1 | 285 | 180 | 5,995 | (254) | (13) | 4,200 | ||
| Fiscal Year - 2 | 272 | 513 | 6,950 | 1 | (11) | 6,222 | ||
| Fiscal Year - 3 | 140 | 889 | 7,725 | 2 | (29) | 5,283 | ||
| Fiscal Year - 4 | 229 | 631 | 6,375 | 3 | (26) | 3,510 | ||
| Fiscal Year - 5 | 96 | 228 | 3,696 | 2 | (61) | 2,364 | ||
| Total Assets | ||||||||
| Latest Fiscal Quarter Prior | 2,721 | 13,433 | 97,095 | 447 | 2,563 | 78,555 | ||
| Latest Fiscal Quarter | 2,644 | 12,361 | 99,041 | 433 | 2,042 | 81,620 | ||
| Fiscal Year | 2,704 | 12,392 | 97,321 | 433 | 2,100 | 77,542 | ||
| Fiscal Year - 1 | 2,639 | 13,565 | 98,726 | 447 | 2,886 | 84,488 | ||
| Fiscal Year - 2 | 2,295 | 14,130 | 97,154 | 662 | 3,716 | 84,350 | ||
| Fiscal Year - 3 | 2,263 | 15,001 | 95,123 | 707 | 1,820 | 83,184 | ||
| Fiscal Year - 4 | 2,028 | 7,960 | 69,052 | 601 | 1,559 | 76,161 | ||
| Fiscal Year - 5 | 1,884 | 6,539 | 58,381 | 409 | 1,516 | 62,082 | ||
| Fiscal Year - 6 | 1,593 | 5,976 | 56,232 | 157 | 1,095 | 47,833 | ||
| Common Equity | ||||||||
| Latest Fiscal Quarter Prior | 2,014 | 7,846 | 45,516 | 145 | 2,223 | 49,897 | ||
| Latest Fiscal Quarter | 2,018 | 7,637 | 49,390 | 160 | 1,701 | 52,334 | ||
| Fiscal Year | 2,069 | 7,667 | 49,584 | 160 | 1,769 | 49,543 | ||
| Fiscal Year - 1 | 1,967 | 7,873 | 46,735 | 145 | 2,535 | 53,486 | ||
| Fiscal Year - 2 | 1,702 | 7,383 | 43,978 | 393 | 3,363 | 48,414 | ||
| Fiscal Year - 3 | 1,563 | 7,141 | 40,793 | 394 | 1,325 | 41,899 | ||
| Fiscal Year - 4 | 1,381 | 3,735 | 34,507 | 406 | 1,214 | 36,498 | ||
| Fiscal Year - 5 | 1,166 | 2,814 | 29,675 | 220 | 1,139 | 28,671 | ||
| Fiscal Year - 6 | 1,079 | 2,585 | 27,586 | 111 | 718 | 28,214 | ||